Literature DB >> 166960

Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.

J L Meyer, L H Smith.   

Abstract

A method is described for quantitatively determining the inhibitory activity of pure components, isolates, or mixtures of components (such as urine) on the growth of calcium oxalate crystals. Results with known calcium phosphate crystal growth inhibitors--magnesium, citrate, and pyrophosphate--suggest that these components contribute little to the ability to normal urine to inhibit the growth of calcium oxalate crystals. As yet unidentified urinary components seem to be responsible for most of this activity. The urinary crystal growth inhibitors appear to function by adsorbing on the surface of the growing crystals, thereby preventing the further incorporation of lattice ions. The fit of experimental data to the Langmuir absorption isotherm supports this conclusion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166960

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  38 in total

1.  The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates.

Authors:  J L Meyer; K E Lee; J H Bergert
Journal:  Calcif Tissue Res       Date:  1977-05-31

2.  Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.

Authors:  Antonia Costa-Bauzá; Catalina Barceló; Juan Perelló; Felix Grases
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.

Authors:  S Sørensen; K Hansen; S Bak; S J Justesen
Journal:  Urol Res       Date:  1990

Review 4.  Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?

Authors:  Roswitha Siener
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

5.  Analysis of calcium, iron, copper and zinc contents of nucleus and crust parts of urinary calculi.

Authors:  I Durak; Z Kilic; A Sahin; M Akpoyraz
Journal:  Urol Res       Date:  1992

6.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Authors:  Y Nakagawa; V Abram; J H Parks; H S Lau; J K Kawooya; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

7.  Evaluation of the relative inhibitory potential of fractionated urinary macromolecules.

Authors:  R Azoury; B Goldwasser; Y Wax; S Perlberg; N Garti; S Sarig
Journal:  Urol Res       Date:  1985

8.  Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.

Authors:  J M Baumann; K Lauber; F X Lustenberger; M Wacker; E J Zingg
Journal:  Urol Res       Date:  1985

9.  May enzyme activity in urine play a role in kidney stone formation?

Authors:  R Azoury; N Garti; S Perlberg; S Sarig
Journal:  Urol Res       Date:  1982

Review 10.  Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urol Res       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.